Genome Canada

Insider Tip

The regional Genome Centre is your most important ally — they are the mandatory gateway for all applications, actively help shape proposals, broker provincial co-funding, and advocate for projects during review. Start the relationship 6-12 months before a competition opens. For industry partners: GAPP is the natural entry point, but the new HARVEST program (launched Feb 2026) offers a faster, simpler pathway for agriculture/agri-food companies. The strongest applications show genuine academic-industry collaboration where both sides contribute meaningfully, not token partnerships assembled for the application.

Rejection Pitfalls 9

• Insufficient or unconfirmed co-funding plan — co-funding is non-negotiable and must be credible at application time
• Weak or token industry partnership — Receptor must demonstrate genuine need and active project participation
• Scientific plan lacks novelty or significance — incremental advances do not compete well in national competitions

Success Profile

University-based principal investigator with strong genomics publication record and prior Genome Canada funding. Multi-institutional team spanning 3-5 universities with complementary expertise. Established industry partnership (not assembled for the grant) with a Receptor organization that co-defines the research challenge and commits meaningful co-funding (cash, not just in-kind). Clear pathway from research to real-world application. Strong GE3LS component with genuine community/stakeholder engagement. Credible co-funding plan with signed letters from provincial Genome Centre, industry partners, and other sources covering 50-67% of total costs.

Evaluation Criteria

Multi-stage peer review assessing: scientific excellence and innovation, strength of academic-industry partnership (genuine collaboration, not token), feasibility and appropriateness of research plan, GE3LS considerations and community engagement, co-funding plan credibility (1/3 Genome Canada, 2/3 co-funding), team track record and expertise, data management and IP strategy, and potential for real-world application and commercialization.

Application Steps

Required Documents 12

Eligible Expenses 8

• Salaries and benefits of project team members directly supporting objectives
• Equipment and research infrastructure (new or donated, valued above $1,000 with useful life over 1 year)
• Consumables and laboratory supplies
• Sequencing and bioinformatics services
• Travel directly related to project collaboration
• Knowledge mobilization and technology transfer activities
• GE3LS (ethical, environmental, economic, legal, social) research costs
• Data management and bioinformatics infrastructure

Ineligible Expenses 7

• Institutional overhead and indirect costs (0% indirect costs for Genome Canada portion)
• Salaries of researchers or senior management funded by their home institutions
• Entertainment and hospitality
• Costs incurred before the Notice of Award (except co-funded expenses up to 6 months prior)
• Capital construction or renovation of buildings
• General administrative costs not directly tied to the project
• Tuition fees

Intake Periods

Program-dependent. GAPP: annual national intake (2025 closed, 2026 forthcoming). R-GAPP: regional intakes vary by Genome Centre. HARVEST: February-April 2026 (new). LSARP: every 2-3 years, thematic. Monitor genomecanada.ca and regional centre websites.

Deadline Notes

Genome Canada runs multiple distinct funding programs with different timelines. GAPP (most business-friendly): 2025 national intake closed, 2026 intake details forthcoming. HARVEST: preliminary applications due March 18, 2026; full applications April 13, 2026. R-GAPP Alberta: Eligibility Form due Feb 11, 2026; Full Proposals May 2026. LSARP (flagship large-scale): no 2026 competition announced yet — typically runs every 2-3 years with thematic focus. Applicants must monitor Genome Canada and their regional Genome Centre websites for competition announcements.

Open Application Portal →

Ineligible Organizations

• Organizations outside Canada
• Applicants without affiliation to a recognized Canadian research institution
• Industry partners unable to provide confirmed co-funding commitments
• Projects not routed through a regional Genome Centre

Compatible Programs

Clawback Risk

Low Risk

Low for grants. Genome Canada funding is primarily non-repayable research grants. However, failure to meet project milestones, misuse of funds, or non-compliance with reporting requirements can result in withholding of future instalments or requirement to return unspent funds. IP commercialization revenue sharing may apply per project-specific agreements.